Placebo-resistant gut bacteria: <i>Akkermansia muciniphila</i> spp. and Familial Mediterranean fever disease.

Authors:
Pepoyan E; Marotta F; Manvelyan A; Galstyan A; Stepanyan L and 9 more

Journal:
Front Cell Infect Microbiol

Publication Year: 2024

DOI:
10.3389/fcimb.2024.1336752

PMCID:
PMC10920240

PMID:
38465231

Journal Information

Journal Title: Front Cell Infect Microbiol

Detailed journal information not available.

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"a total of 15 healthy and 15 fmf male volunteers aged 18 to 50 participated in this partially randomized placebo trial which is accessible through the geo series accession number gse111835.; healthy and fmf male volunteers (15/15) aged 18 to 50 took part in this partially randomized placebo trial accessible through geo series accession number gse111835 ( ; ) in which the participant took an empty capsule twice daily as a placebo for 1 month."

Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the State Committee of Science, Armenia (project 21AG-4D065)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025